Current Report Filing (8-k)

Date : 11/29/2017 @ 2:07PM
Source : Edgar (US Regulatory)
Stock : Lexaria Bioscience Corp. (QB) (LXRP)
Quote : 1.7  0.45 (36.00%) @ 4:00PM

Current Report Filing (8-k)


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) November 27, 2017

LEXARIA BIOSCIENCE CORP.
(Exact name of registrant as specified in its charter)

Nevada 000-52138 20-2000871
(State or other jurisdiction of (Commission File Number) (IRS Employer
incorporation)   Identification No.)

156 Valleyview Road, Kelowna, BC Canada V1X 3M4
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code (250) 765-6424

N/A
(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[     ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[     ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
[     ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
[     ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b -2 of this chapter).

Emerging growth company [     ] 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

[     ] 

Item 3.02 Unregistered Sales of Equity Securities

Lexaria has received US$118,913 from the exercise of warrants and a compensation option certificate previously granted. The compensation option certificate was exercised at the price of US$0.42. The stock warrants were exercised at prices of US$0.14, US$0.273, and US$0.60, for a total of 415,187 common shares being issued. All exercises are by third parties who are neither officers nor directors of the Company. Following issuance of these common shares, Lexaria will have 69,435,198 common shares issued and outstanding. No commissions or placement fees have been paid related to the funds received from these warrants exercised. Proceeds will be used for general corporate purposes.


- 2 -

The securities referred to herein will not be or have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

Additionally, Lexaria is attending and delivering a presentation at the upcoming 10 th annual LD Micro Main Event on December 5-7 located in Los Angeles and filing its annual 10K with Securities and Exchange Commission.

Item 7.01 Regulation FD Disclosure

A copy of the news release announcing that Lexaria has received US$118,913 from a warrant exercise previously granted is filed as exhibit 99.1 to this current report and is hereby incorporated by reference.

Item 9.01 Financial Statements and Exhibits
99.1 Press Release dated November 27, 2017

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

LEXARIA BIOSCIENCE CORP.

/s/ Chris Bunka  
Chris Bunka  
CEO, Principal Executive Officer  

Date: November 27, 2017


Lexaria Bioscience Corp. (USOTC:LXRP)
Historical Stock Chart

1 Year : From Dec 2016 to Dec 2017

Click Here for more Lexaria Bioscience Corp. Charts.

Lexaria Bioscience Corp. (USOTC:LXRP)
Intraday Stock Chart

Today : Tuesday 12 December 2017

Click Here for more Lexaria Bioscience Corp. Charts.

Latest LXRP Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.